Imunon, Inc. (IMNN): Nasdaq/NYSE listing notice — Nasdaq panel grants Imunon listing compliance exception; equity plan expanded by 2M shares

Imunon, Inc.

Nasdaq Hearing Panel granted Imunon an exception to regain compliance with minimum bid price ($1.00) and stockholders' equity ($5M) requirements.
Company had previously received delisting determination for not meeting minimum bid price and equity requirements.
Imunon must promptly notify Panel of significant events; no assurance of regaining compliance.
Stockholders approved amendment to 2018 Stock Incentive Plan, increasing shares by 2,000,000 to total 3,970,000 shares.
If delisted, stock could suffer material decline and impair capital raising.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Imunon, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5505(b), 5550(b)(1), 5810(d)(2)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5505(b), 5550(b)(1), 5810(d)(2)

Exact text from the filing

July 11, 2025, the Panel notified the Company that it has granted Company’s request for an exception (the “Exception”) tailored to the time needed for the Company to regain compliance with the Minimum Bid Price Requirement and the Minimum Stockholders’ Equity Requirement. Pursuant to the Exception, the Company is required to provide the Panel with prompt notification of any significant events that occur, including any event that may call into question the Company’s ability to satisfy the terms of the Exception. There can be no assurance that the Company will be able to regain compliance with t

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Imunon, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-019541

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.